Comparative investigation of treatments for evaporative dry eye;Vergleichende untersuchung zur therapie des evaporativen trockenen auges

Klinische Monatsblatter fur Augenheilkunde

Volumn 227, Issue 2, 2010, Pages 128-134

  Khaireddin, Riad ^a,c   Schmidt, K G ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b AKS ^*  (Germany)

^c Augenklinik Hannover Zentrum   (Germany)

Author keywords

Conjunctiva; Contact lenses; Cornea; Lids; Nasolacrimal ducts; Pharmacology

Indexed keywords

ARTIFICIAL TEAR; EYE DROPS; HYALURONIC ACID; LIPOSOME; PHOSPHOLIPID; TEARS AGAIN; UNCLASSIFIED DRUG; VISMED;

ADULT; AEROSOL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY EYE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TEAR FILM;

ADMINISTRATION, TOPICAL; ADULT; DRY EYE SYNDROMES; FEMALE; HUMANS; HYALURONIC ACID; LIPOSOMES; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PHOSPHOLIPIDS; PROSPECTIVE STUDIES;

EID: 77349085103     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109686     Document Type: Article

References (42)

1. Aragona P, Di Stefano G, Ferreri F et al. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients. Br J Ophthalmol 2002; 86: 879-884
2. Aragona P, Papa V, Micali A et al. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002; 86: 181-184
3. Auw-Hädrich C, Reinhard T. Chronische Blepharitis. Ophthalmologe 2007; 104: 817-828
4. Bernauer W, Thiel MA, Kurrer M et al. Corneal calcification following intensified treatment with sodium hyaluronate artificial tears. Br J Ophthalmol 2006; 90: 285-288
5. Brewitt H. Therapie des trockenen Auges. In: Messmer E (Hrsg). Diagnose und Therapie des trockenen Auges. 2. Auflage. Bremen: UNIMED, 2007
6. Bron AJ, Tiffany JM, Gouveia SM et al. Functional aspects of the tear film lipid layer. Exp Eye Res 2004; 78: 347-360
7. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf 2004; 2: 149-165
8. th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance, Taormina, Sicily, Italy, 2007 Conference Program and Abstract Book 2007: 59
9. Dausch D, Lee S, Dausch S et al. Vergleichende Studie zur Therapie des trockenen Auges bedingt durch Lipidphasenstörungen mit lipidhaltigen Tränenpräparaten. Klin Monatsbl Augenheilkd 2006; 223: 974-983
10. Definition und Klassifikation des trockenen Auges: Bericht des Unterausschusses für Definition und Klassifikation des International Dry Eye WorkShop 2007; 5: 75-92
11. Guillon JP. Abnormal Lipid Layer. Observation, Differential Diagnosis, and Classification. In: Sullivan D et al. (Hrsg). Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York: Plenum Press, 1998: 309-313
12. Heiligenhaus A, Koch JM, Kruse FE et al. Diagnostik und Differenzierung von Benetzungsstörungen. Ophthalmologe 1995; 92: 6-11
13. Heiligenhaus A, Koch JM, Kemper D et al. Therapie von Benetzungsstörungen. Klin Monatsbl Augenheilkd 1994; 204: 162-168
14. Höh H, Schirra F, Kienecker C et al. Lidparallele konjunctivale Falten (LIPCOF) sind ein sicheres diagnostisches Zeichen des trockenen Auges. Ophthalmologe 1995; 17: 104-117
15. Holly FJ. The preocular tear film; a small but highly complex part of the eye. Arch Soc Esp Oftalmol 2005; 80: 65-68
16. Horwath-Winter J, Berghold A, Schmut O et al. Evaluation of the clinical course of dry eye syndrome. Arch Ophthalmol 2003; 121: 1364-1368
17. Johnson ME, Murphy PJ, Boulton M. Carbomer and sodium hyaluronate yedrops formoderate dry eye treatment. Optom Vis Sci 2008; 85: 750-757
18. Johnson ME, Murphy PJ, Boulton M. Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefes Arch Clin Exp Ophthalmol 2006; 244: 109-112
19. Kaercher T, Brewitt H. Blepharitis- und Sicca-Sprechstunde. Z prakt Augenheilkd 2003; 24: 99-102
20. Kruse F. Therapie des "trockenen Auges". In: Kampik A, Grehn F (Hrsg). Augenärztliche Therapie. 1. Auflage. Stuttgart: Thieme, 2002: 359-374
21. Lang GK. Augenheilkunde. 4., überarbeitete Auflage. In: Thieme (Hrsg). Stuttgart, 2008
22. Lee S, Dausch S, Maierhofer G et al. Ein neues Therapiekonzept zur Behandlung des trockenen Auges - die Verwendung von Phospholipid-Liposomen. Klin Monatsbl Augenheilkd 2004; 221: 825-836
23. Lemp MA. Pathogenesis and Classification of the Dry Eye Disease. In: Asbell PA, Lemp MA (Hrsg). Dry eye disease. New York: Thieme, 2006: 16-23
24. Lozato PA, Pisella PJ, Baudouin C. Phase lipidique du film lacrymal: physiologie et pathologie. J Fr Ophtalmol 2001; 24: 643-658
25. Mathers W. Evaporation from the ocular surface. Exp Eye Res 2004; 78: 389-394
26. Matsuo T. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye. Jpn J Ophthalmol 2004; 48: 321-327
27. McCulley JP, Shine WE. The lipid layer: the outer surface of the ocular surface tear film. Biosci Rep 2001; 21: 407-418
28. Messmer E. Pathogenese des trockenen Auges. 2. Auflage In: Messmer E (Hrsg). Diagnose und Therapie des trockenen Auges. Bremen: UNIMED, 2007: 6-18
29. Nepp J, Schauersberger J, Schild G et al. The clinical use of viscoelastic artificial tears and sodium chloride in dry eye syndrome. Biomaterials 2001; 22: 3305-3310
30. Ousler GW, Michaelson C, Christensen MT. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops. Cornea 2007; 26: 949-952
31. Peters K, Millar TJ. The role of different phospholipids on tear break-up time using a model eye. Curr Eye Res 2002; 25: 55-60
32. Prabhasawat P, Tesavibul N, Kasetsuwan N. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomized, double-blind, controlled, exploratory study. Br J Ophthalmol 2007; 91: 47-50
33. Rolando M, Valente C. Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study. BMC Ophthalmol 2007; 7: 5
34. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. rch Ophthalmol 1995; 113: 1266-1270
35. Shine WE, McCulley JP. Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol 1998; 116: 849-852
36. Shine WE, McCulley JP. Meibomianitis: polar lipid abnormalities. Cornea 2004; 23: 781-783
37. Song CH, Choi JS, Kim DK et al. Enhanced secretory group II PLA2 activity in the tears of chronic blepharitis patients. Invest Ophthalmol Vis Sci 1999; 40: 2744-2748
38. Tiffany JM. The normal tear film. Dev Ophthalmol 2008; 41: 1-20
39. Tomlinson A. Epidemiology of dry eye disease. In: Asbell PA, Lemp MA (Hrsg). Dry eye disease. New York: Thieme, 2006: 1-15
40. Troiano P, Monaco G. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study. Cornea 2008; 27: 1126-1130
41. Tuft S, Lakhani S. Medical management of dry eye disease. Dev Ophthalmol 2008; 41: 54-74
42. Bortz J. Statistik für Human- und Sozialwissenschaftler. 6. Auflage. Heidelberg: Springer, 2005